Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $545.86 | 18 | 84.6% |
| Education | $99.00 | 1 | 15.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $152.78 | 6 | $0 (2024) |
| ABBVIE INC. | $144.89 | 2 | $0 (2022) |
| Daiichi Sankyo Inc. | $112.43 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $99.00 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $58.10 | 2 | $0 (2024) |
| Genentech USA, Inc. | $29.91 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.57 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $22.18 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $393.88 | 13 | Daiichi Sankyo Inc. ($112.43) |
| 2023 | $106.09 | 4 | Celgene Corporation ($75.34) |
| 2022 | $144.89 | 2 | ABBVIE INC. ($144.89) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: BioOncology | ||||||
| 08/02/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $31.06 | General |
| Category: Hematology | ||||||
| 06/03/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 05/03/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.23 | General |
| Category: Hematology | ||||||
| 04/24/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: ONCOLOGY | ||||||
| 04/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), DIFICID | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/11/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $28.15 | General |
| Category: Hematology | ||||||
| 02/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Rare Disease | ||||||
| 01/22/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $27.66 | General |
| Category: Hematology | ||||||
| 10/16/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $27.64 | General |
| Category: Hematology | ||||||
| 07/19/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Rare Disease | ||||||
| 01/27/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.04 | General |
| Category: Hematology | ||||||
| 11/17/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $19.89 | General |
| 08/16/2022 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 24 | $6,144 | $1,497 |
| 2022 | 2 | 60 | 134 | $32,168 | $8,906 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 24 | $6,144 | $1,497 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 40 | 110 | $28,160 | $7,789 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 24 | $4,008 | $1,116 | 27.9% |
About Erika Krisha Ongoco, NP
Erika Krisha Ongoco, NP is a Gerontology healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2012. The National Provider Identifier (NPI) number assigned to this provider is 1174870331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erika Krisha Ongoco, NP has received a total of $644.86 in payments from pharmaceutical and medical device companies, with $393.88 received in 2024. These payments were reported across 19 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($545.86).
As a Medicare-enrolled provider, Ongoco has provided services to 77 Medicare beneficiaries, totaling 158 services with total Medicare billing of $10,403. Data is available for 2 years (2022–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Gerontology
- Other Specialties Adult Health
- Location Long Beach, CA
- Active Since 08/07/2012
- Last Updated 12/06/2021
- Taxonomy Code 363LG0600X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174870331
Products in Payments
- REBLOZYL (Biological) $152.78
- VENCLEXTA (Drug) $125.00
- Vanflyta (Drug) $112.43
- ULTOMIRIS (Biological) $58.10
- Venclexta (Biological) $29.91
- ICLUSIG (Drug) $25.57
- PREVYMIS (Drug) $22.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gerontology Doctors in Long Beach
Mrs. Mary Joy Floresca, Np, NP
Gerontology — Payments: $349.79
Stephanie Luckanavanich, Ag-Acnp, AG-ACNP
Gerontology — Payments: $118.79
Virginia Cule
Gerontology — Payments: $104.15
Mr. Lawrence Lemos, Rn, RN
Gerontology — Payments: $47.48
Dr. Catherine Caston, Aprn, Cns, APRN, CNS
Gerontology
Linda Pittman
Gerontology